In their assessment of cases from 2 large publicly-available BC datasets, Fertig et al. found that IL6ST was significantly overexpressed (p = 2 × 10 − 16) in tumours classified as luminal A or luminal B intrinsic subtypes (characterised by ER+/PR+ status) [42], consistent with previous reports of lower levels in TNBC. Here, IL6ST is linked to breast cancer.